Vital Specialized Biopharmaceutical Insights and Analytics
for Experts from Experts
BioTrends is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
Although there are many treatments available for RA, there is still a high unmet need for new treatments, especially for patients who are refractory to current therapies, such as TNF-alpha inhibitors, the most widely used biologic agents in RA...
Age-related macular degeneration (AMD) is the leading cause of visual impairment and blindness in the United States, with vision loss occurring predominately in patients with the wet form of the disease. In order to better understand the actual treatment of wet AMD patients with anti-VEGF agents, the preferred treatment option, BioTrends Research Group is pleased to announce the upcoming publication of the inaugural ChartTrends: Wet Age-Related Macular Degeneration US report in June...